EMILY REEVES: Open Payments
NPI 1609587088 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,606 in 79 payments from 20 companies in 2025. Trend: 2023 $915 · 2024 $1,313 · 2025 $1,606
Food & beverage: $1,507Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $276 |
| Novo Nordisk Inc | 14 | $253 |
| Astellas Pharma US Inc | 6 | $194 |
| AstraZeneca Pharmaceuticals LP | 5 | $157 |
| PFIZER INC. | 5 | $112 |
| Lilly USA, LLC | 6 | $107 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| Exact Sciences Corporation | 4 | $76 |
| Abbott Laboratories | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
Products named: VRAYLAR, Ozempic, FARXIGA, QULIPTA, Veozah, NURTEC ODT, MOUNJARO, Cologuard Collection Kit.
Industry payments across TN — which companies pay providers there.
